No abstract

The extract is non-toxic even at relatively high concentrations. The anti-ulcer activity is probably due to the presence of flavanoids.

The results of our study suggest that BSEt possesses a promising effect on STZ-nicotinamide-induced diabetes.

The present investigation aims to examine the diabetic potential of the plant Ficus racemosa in normal and alloxan induced diabetic rats. The bark extract with water, petroleum ether and with alcohol were screened for blood glucose lowering activity and the alcoholic extract having better therapeutic potential was prepared through Soxhlet extraction for further study. Alcoholic and aqueous extract of bark of Ficus racemosa at a dose of 400 mg/Kg was given to normal and alloxan induced diabetic rats and the blood samples taken from the retero-orbital plexus vein were analyzed for blood glucose level as per standard protocol with available kits through Auto-analyzer. The comparison of blood sugar level as per model schedule showed that in normal group the ethanolic extract, at a dose of 400 mg/Kg intra-peritoneal, the blood glucose lowering 28.66 % while in aqueous extract given group it was 25.90 %. In alloxan induced diabetic rats decrease in blood glucose level in aqueous and ethanolic extract group was found to be 27.01 % and 45.03 % respectively. In conclusion, the ethanolic extract of Ficus racemosa reflected anti-diabetic potential through its glucose lowering activity in experimental animals. It supported the folklore claim of anti-diabetic activity of the plant.

Inflammatory diseases, including rheumatic, diseases are a major cause of morbidity of the working force throughout the world. Inflammation is a tissue reaction to infection. The effects are redness (erythema), swelling (oedema) and pain, to the area that can result in loss of function. Cyanobacteria are photosynthetic prokaryotic organisms which are potentially useful in pharmaceuticals, industrial chemicals, and restriction enzymes. Trichodesmium species are non-heterocystous cyanobacteria, commonly found in tropical and subtropical oligotrophic oceans. They occur in filaments of 20-200 cells which often congregate to form larger colonies called blooms that can be seen and often form dense blooms covering vast areas in sub-tropical regions. The present study tested the anti-inflammatory effect of the marine cyanobacterium, Trichodesmium erythraeum in carrageenan-induced inflammation in rats. The aqueous extract showed anti-inflammatory activity at a high dosage (500 mg/kg) and this effect was on par with the commercial drug, indomethacin. The inhibition of inflammation volume was 57.5±5.5 % and 47.5±4.7% respectively, at higher and lower dosages, in 30 minutes of treatment. The control group without any treatment exhibited an increase in the paw volume. This is the first report on the anti-inflammatory effect of marine-derived Trichodesmium erythraeum.Trichodesmium species are non-heterocystous .cyanobacteria commonly found in tropical and subtropical oligotrophic oceans. They occur in filaments of 20-200 cells which often congregate to form larger colonies called blooms that can be seen and often form dense blooms covering vast areas in sub-tropical regions (1). These organisms are of considerable interest to biological oceanographers because of their reputed ability to fix nitrogen (2). Many studies have proved anti-inflammatory potential of cyanobacterial species (3). Most of these works are restricted to terrestrial organisms, but not in marine species. Since marine organisms thrive in extreme conditions, they should not be ignored in the search for novel metabolites (4). Hence, the present study investigated the anti-inflammatory property of marine cyanobacterial species Trichodesmium erythraeum using an animal model. MATERIALS AND METHODSThe samples of Trichodesmium erythraeum were

No abstract

No abstract

COVID-19 is the infectious pandemic disease caused by the novel coronavirus. The COVID-19 is spread globally in a short span of time. The Ministry of AYUSH, India which promotes Siddha and other Indian system of medicine recommends the use of formulation like Nilavembu Kudineer and Kaba Sura Kudineer Chooranam (KSKC). The present work seeks to provide the evidence for the action of 74 different constituents of the KSKC formulation acting on two critical targets. That is main protease and SARS-CoV-2 RNAdependent RNA polymerase target through molecular docking studies. The molecular docking was done by using AutoDock Tools 1.5.6 of the 74 compounds, about 50 compounds yielded docking results against COVID-19 main protease while 42 compounds yielded against SARSCoV- 2 RNA-dependent RNA polymerase. This research has concluded that the KSKC has the lead molecules that inhibits COVID-19’s target of main protease of COVID-19 and SARS-CoV-2 RNA-dependent RNA polymerase.